Estep Jonathan S 4
4 · Leslie's, Inc. · Filed Mar 26, 2026
Research Summary
AI-generated summary of this filing
Leslie's (LESL) Director Jonathan Estep Receives 4,500 RSUs
What Happened
Jonathan S. Estep, a director of Leslie's, Inc. (LESL), was reported as acquiring 4,500 derivative shares on 2026-03-24. The Form 4 shows an acquisition of 4,500 units at $0.00 (total reported value $0) — these units are restricted stock units (RSUs), i.e., a contingent right to receive one share per RSU upon vesting. This is an equity award/derivative transaction, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-03-24; Form 4 filed: 2026-03-26 (appears timely).
- Transaction type/code: Derivative grant/conversion (Form 4 shows "M"); 4,500 RSUs acquired at $0.00.
- Reported value: $0 (RSUs are not a cash purchase at grant).
- Vesting: RSUs vest on the earlier of (a) March 24, 2027 or (b) the day before the Company's March 2027 annual meeting, subject to Mr. Estep's continuous service through the vesting date (per filing footnote).
- Shares owned after transaction: Not specified in the provided filing details.
- Footnotes: F1 clarifies each RSU converts to one share upon vesting; F2 details the vesting schedule tied to service through the Vesting Date.
Context
RSU grants are common director compensation and represent future rights to company shares if vesting conditions are met. Because these units vest in the future and were granted at $0, this filing does not reflect an immediate purchase or sale of stock and should be viewed as compensation rather than a direct market signal.
Insider Transaction Report
- Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-03-24+4,500→ 4,500 totalExercise: $0.00→ Common Stock, par value $0.001 per share (4,500 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Common Stock.
- [F2]Represents a grant of 4,500 RSUs which will vest on the earlier of (a) March 24, 2027 or (b) the day prior to the Company's Annual Meeting of Shareholders held in March 2027 (the earlier of (a) and (b) referred to as the "Vesting Date"), subject to Mr. Estep's continuous service as a member of the Board until the Vesting Date.